Sandy Spring Bank’s AbbVie ABBV Stock Holding History

Sandy Spring Bank’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$5.9M	Sell	28,179 -7,314	-21%	-$1.42M	0.25%	86
2024 Q4	$6.31M	Sell	35,493 -2,106	-6%	-$387K	0.26%	82
2024 Q3	$7.43M	Sell	37,599 -9	-0%	-$1.68K	0.31%	74
2024 Q2	$6.45M	Sell	37,608 -973	-3%	-$161K	0.28%	73
2024 Q1	$7.03M	Sell	38,581 -1,358	-3%	-$234K	0.32%	72
2023 Q4	$6.19M	Sell	39,939 -4,136	-9%	-$603K	0.31%	73
2023 Q3	$6.57M	Sell	44,075 -1,631	-4%	-$239K	0.37%	65
2023 Q2	$6.16M	Sell	45,706 -2,986	-6%	-$438K	0.33%	71
2023 Q1	$7.76M	Sell	48,692 -211	-0.4%	-$32.3K	0.44%	55
2022 Q4	$7.9M	Buy	48,903 +8,300	+20%	+$1.27M	0.47%	53
2022 Q3	$5.45M	Sell	40,603 -2,846	-7%	-$408K	0.35%	69
2022 Q2	$6.66M	Sell	43,449 -759	-2%	-$116K	0.4%	61
2022 Q1	$7.17M	Sell	44,208 -2	-0%	-$291	0.36%	66
2021 Q4	$5.99M	Buy	44,210 +188	+0.4%	+$22.2K	0.29%	86
2021 Q3	$4.75M	Sell	44,022 -1,681	-4%	-$192K	0.25%	99
2021 Q2	$5.15M	Buy	45,703 +840	+2%	+$94.6K	0.27%	92
2021 Q1	$4.86M	Sell	44,863 -2,748	-6%	-$294K	0.28%	92
2020 Q4	$5.1M	Sell	47,611 -939	-2%	-$90.2K	0.31%	81
2020 Q3	$4.25M	Sell	48,550 -303	-0.6%	-$28.5K	0.29%	87
2020 Q2	$4.79M	Buy	48,853 +1,859	+4%	+$164K	0.36%	74
2020 Q1	$3.58M	Sell	46,994 -2,131	-4%	-$182K	0.32%	78
2019 Q4	$4.35M	Sell	49,125 -2,516	-5%	-$209K	0.32%	83
2019 Q3	$3.91M	Sell	51,641 -1,291	-2%	-$88.5K	0.31%	82
2019 Q2	$3.85M	Sell	52,932 -6,829	-11%	-$537K	0.31%	84
2019 Q1	$4.82M	Sell	59,761 -41,463	-41%	-$3.39M	0.41%	66
2018 Q4	$9.33M	Sell	101,224 -8,012	-7%	-$705K	0.89%	23
2018 Q3	$10.3M	Sell	109,236 -1,758	-2%	-$167K	0.85%	27
2018 Q2	$10.3M	Buy	110,994 +2,023	+2%	+$198K	0.89%	24
2018 Q1	$10.3M	Sell	108,971 -714	-0.7%	-$78.4K	0.91%	20
2017 Q4	$10.6M	Buy	109,685 +107	+0.1%	+$10.1K	0.97%	23
2017 Q3	$9.74M	Sell	109,578 -1,336	-1%	-$102K	0.93%	20
2017 Q2	$8.07M	Sell	110,914 -1,913	-2%	-$129K	0.79%	30
2017 Q1	$7.38M	Buy	112,827 +810	+0.7%	+$50.9K	0.73%	34
2016 Q4	$7.04M	Buy	112,017 +1,183	+1%	+$72.2K	0.73%	33
2016 Q3	$7.02M	Buy	110,834 +11,381	+11%	+$737K	0.75%	32
2016 Q2	$6.2M	Buy	99,453 +4,039	+4%	+$246K	0.71%	32
2016 Q1	$5.45M	Buy	95,414 +9,548	+11%	+$532K	0.62%	38
2015 Q4	$5.09M	Buy	85,866 +12,160	+16%	+$700K	0.59%	43
2015 Q3	$4.01M	Buy	73,706 +2,884	+4%	+$188K	0.49%	57
2015 Q2	$4.76M	Buy	70,822 +7,470	+12%	+$488K	0.54%	52
2015 Q1	$3.71M	Buy	63,352 +10,494	+20%	+$634K	0.43%	70
2014 Q4	$3.46M	Buy	52,858 +1,913	+4%	+$121K	0.41%	71
2014 Q3	$2.94M	Buy	50,945 +4,916	+11%	+$273K	0.36%	83
2014 Q2	$2.6M	Buy	46,029 +4,235	+10%	+$222K	0.33%	89
2014 Q1	$2.15M	Buy	41,794 +1,662	+4%	+$84K	0.33%	94
2013 Q4	$2.12M	Sell	40,132 -221	-0.5%	-$10.9K	0.3%	101
2013 Q3	$1.8M	Buy	40,353 +1,525	+4%	+$67.6K	0.27%	106
2013 Q2	$1.6M	Buy	+38,828	New	+$1.7M	0.25%	111

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Sandy Spring Bank's ABBV Position: Q1 2025 in Review

Sandy Spring Bank reduced its AbbVie (ABBV) stake by 21% in Q1 2025, selling an estimated $1.42M and leaving 28,179 shares worth $5.9M. The position accounts for 0.25% of the portfolio, ranked #86.

Sandy Spring Bank first reported a position in ABBV in Q2 2013 and has held it in 48 quarters since. The position peaked at $10.6M in Q4 2017. 3,820 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

Sandy Spring Bank held 28,179 shares of AbbVie worth $5.9M as of Q1 2025.
Sandy Spring Bank sold 7,314 AbbVie shares in Q1 2025, an estimated $1.42M.
AbbVie made up 0.25% of Sandy Spring Bank's portfolio in Q1 2025, its #86 holding.
Sandy Spring Bank first reported a position in AbbVie in Q2 2013 and has held it in 48 quarters since.
Sandy Spring Bank's AbbVie position peaked at $10.6M in Q4 2017.
3,820 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.